Terms: = Leukemia AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Prognosis
71 results:
1. [Clinical features and prognosis of core binding factor acute myeloid leukemia children in South China: a multicenter study].
Guo BY; Wang Y; Li J; Li CF; Feng XQ; Zheng MC; Liu SX; Yang LH; Jiang H; Xu HG; He XL; Wen H
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):881-888. PubMed ID: 37803854
[No Abstract] [Full Text] [Related]
2. Exploring Prognostic Biomarkers of Acute Myeloid leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation.
Alom MM; Faruqe MO; Molla MKI; Rahman MM
Biomed Res Int; 2023; 2023():1946703. PubMed ID: 37359050
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia.
Ding Y; Liu Z; Wang H; Xiong S; Zhai Z
Scand J Clin Lab Invest; 2023 Sep; 83(5):340-347. PubMed ID: 37355341
[TBL] [Abstract] [Full Text] [Related]
4. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K
Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992
[TBL] [Abstract] [Full Text] [Related]
5. [Efficacy and Safety of Decitabine Combined with Modified EIAG Regimen in the Treatment of Patients with Relapsed/Refractory Acute Myeloid leukemia and High-risk Myelodysplastic Syndrome].
Mao JP; Xue LG; Zhu YX; Jia T; Wang Y; Miao L; Wei JF; Zhao LD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):338-343. PubMed ID: 37096503
[TBL] [Abstract] [Full Text] [Related]
6. A Novel Identified Necroptosis-Related Risk Signature for prognosis Prediction and Immune Infiltration Indication in Acute Myeloid leukemia Patients.
Sun Y; Wang R; Xie S; Wang Y; Liu H
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292722
[TBL] [Abstract] [Full Text] [Related]
7. Clinical characteristics and prognostic factors in intracranial hemorrhage patients with hematological diseases.
Zhang JY; Li Y; Ma YS; Sun XJ; Liu YZ; Yin YK; Hu B; Su MH; Li QL; Mi YC; Li DP
Ann Hematol; 2022 Dec; 101(12):2617-2625. PubMed ID: 36178488
[TBL] [Abstract] [Full Text] [Related]
8. Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation.
Nagayama T; Fujiwara SI; Kikuchi T; Onda K; Murahashi R; Nakashima H; Ikeda T; Matsuoka S; Kawaguchi SI; Toda Y; Ito S; Ban T; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Ohmine K; Kanda Y
Leuk Lymphoma; 2022 Jul; 63(7):1694-1700. PubMed ID: 35156892
[TBL] [Abstract] [Full Text] [Related]
9. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma.
Brivio E; Baruchel A; Beishuizen A; Bourquin JP; Brown PA; Cooper T; Gore L; Kolb EA; Locatelli F; Maude SL; Mussai FJ; Vormoor-Bürger B; Vormoor J; von Stackelberg A; Zwaan CM
Eur J Cancer; 2022 Mar; 164():1-17. PubMed ID: 35121370
[TBL] [Abstract] [Full Text] [Related]
10. Invasive Fungal Infections in Children with leukemia: Clinical Features and prognosis.
Sezgin Evim M; Tüfekçi Ö; Baytan B; Ören H; Çelebi S; Ener B; Üstün Elmas K; Yılmaz Ş; Erdem M; Hacımustafaoğlu MK; Güneş AM
Turk J Haematol; 2022 Jun; 39(2):94-102. PubMed ID: 34792308
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathological features and prognostic significance of programmed death ligand 1 in pediatric alk-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan.
Iwafuchi H; Nakazawa A; Sekimizu M; Mori T; Osumi T; Iijima-Yamashita Y; Ohki K; Kiyokawa N; Fukano R; Saito AM; Horibe K; Kobayashi R;
Hum Pathol; 2021 Oct; 116():112-121. PubMed ID: 34363798
[TBL] [Abstract] [Full Text] [Related]
12. Primary and secondary central nervous system mature T- and NK-cell lymphomas.
Pang Y; Chihara D
Semin Hematol; 2021 Apr; 58(2):123-129. PubMed ID: 33906722
[TBL] [Abstract] [Full Text] [Related]
13. Treatment of Relapsed and Refractory alk-Positive Anaplastic Large Cell Lymphoma With alk-Specific Tyrosine Kinase Inhibitor in Children: A Case Series.
Shen D; Song H; Zhang J; Liao C; Wang Y; Fang M; Tang Y
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e1-e4. PubMed ID: 33661174
[TBL] [Abstract] [Full Text] [Related]
14. Leukaemic relapse of anaplastic large cell lymphoma, alk negative.
Karki NR; Badin K; Savage N; Bryan L
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33619137
[TBL] [Abstract] [Full Text] [Related]
15. Development and validation of a prognostic model for adult patients with acute myeloid leukaemia.
Ma TT; Lin XJ; Cheng WY; Xue Q; Wang SY; Liu FJ; Yan H; Zhu YM; Shen Y
EBioMedicine; 2020 Dec; 62():103126. PubMed ID: 33232873
[TBL] [Abstract] [Full Text] [Related]
16. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.
Liu W; Ji X; Song Y; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Ying Z; Zhang C; Deng L; Wu M; Feng F; Leng X; Sun Y; Du T; Zhu J
Cancer Med; 2020 Jun; 9(11):3765-3774. PubMed ID: 32281275
[TBL] [Abstract] [Full Text] [Related]
17. SF3B1 Mutation but Not Ring Sideroblasts Identifies a Specific Group of Myelodysplastic Syndrome-Refractory Cytopenia With Multilineage Dysplasia.
Xiong B; Xue M; Yu Y; Wu S; Zuo X
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):329-339.e3. PubMed ID: 32037286
[TBL] [Abstract] [Full Text] [Related]
18. Expression of RRBP1 in epithelial ovarian cancer and its clinical significance.
Ma J; Ren S; Ding J; Liu S; Zhu J; Ma R; Meng F
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285390
[TBL] [Abstract] [Full Text] [Related]
19. [NPM1 High Mutant Allele Burden is an Adverse Prognostic Factor for AML Patients with Mutated NPM1].
Hou JX; Wang SJ; Liu YF; Hao QQ; Wang C; Li T; Bai JJ; Liao LX; Guo CY; Chang YY; Wang M; Sun H; Xie XS; Jiang ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):365-372. PubMed ID: 30998139
[TBL] [Abstract] [Full Text] [Related]
20. Genomic subtyping and therapeutic targeting of acute erythroleukemia.
Iacobucci I; Wen J; Meggendorfer M; Choi JK; Shi L; Pounds SB; Carmichael CL; Masih KE; Morris SM; Lindsley RC; Janke LJ; Alexander TB; Song G; Qu C; Li Y; Payne-Turner D; Tomizawa D; Kiyokawa N; Valentine M; Valentine V; Basso G; Locatelli F; Enemark EJ; Kham SKY; Yeoh AEJ; Ma X; Zhou X; Sioson E; Rusch M; Ries RE; Stieglitz E; Hunger SP; Wei AH; To LB; Lewis ID; D'Andrea RJ; Kile BT; Brown AL; Scott HS; Hahn CN; Marlton P; Pei D; Cheng C; Loh ML; Ebert BL; Meshinchi S; Haferlach T; Mullighan CG
Nat Genet; 2019 Apr; 51(4):694-704. PubMed ID: 30926971
[TBL] [Abstract] [Full Text] [Related]
[Next]
